21-hydroxylase deficiency classification

Jump to navigation Jump to search

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

21-hydroxylase deficiency classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 21-hydroxylase deficiency classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 21-hydroxylase deficiency classification

CDC on 21-hydroxylase deficiency classification

21-hydroxylase deficiency classification in the news

Blogs on 21-hydroxylase deficiency classification

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Risk calculators and risk factors for 21-hydroxylase deficiency classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ahmad Al Maradni, M.D. [3]

Overview

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency may be classified into several subtypes based on severity, time of onset (mild, moderate, and sever), and the presence of virilization (stage I to stage V).

Classification

Based on severity and time of onset

  • Severe 21-hydroxylase deficiency causes salt-wasting congenital adrenal hyperplasia, with life-threatening vomiting and dehydration occurring within the first few weeks of life. It is also the most common cause of ambiguous genitalia due to prenatal virilization of genetically female (XX) infants.
  • Moderate 21-hydroxylase deficiency is referred to as simple virilizing congenital adrenal hyperplasia and typically is recognized as causing virilization of prepubertal children.
  • Still milder forms of 21-hydroxylase deficiency is referred to as non-classical congenital adrenal hyperplasia and can cause androgenic effects and infertility in adolescent and adult women.[1]

Based on virilization of females infant

Depending on the severity of hyperandrogenism, a female infant can be mildly affected or severely virilized as to appear to be a male. Andrea Prader devised the following Prader scale as a way of describing the degree of virilization.[1]

  • Stage I:
  • Infant has a mildly large clitoris and slightly reduced vaginal opening size. This degree may go unnoticed or may be simply assumed to be within normal variation.
  • Stages II and III:
  • Represent progressively more severe degrees of virlization. The genitalia is obviously abnormal to the eye, with a phallus intermediate in size and a small vaginal opening.
  • Stage IV:
  • Looks more male than female, with an empty scrotum and a phallus with normal size. The phallus is not free enough from the perineum to be pulled into the abdomen towards the umbilicus with a single small urethral/vaginal opening at the base or on the shaft of the phallus.
  • Stage V:
  • Denotes complete male virilization, with a normally formed penis with the urethral opening at or near the tip. The scrotum is normally formed, but empty. The internal pelvic organs include normal ovaries and uterus. These infants are not visibly ambiguous and usually assumed to be ordinary boys with undescended testes.

References

Template:WikiDoc Sources